Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H
Department of Microbiology, Kumamoto University School of Medicine.
Jpn J Cancer Res. 1998 Mar;89(3):307-14. doi: 10.1111/j.1349-7006.1998.tb00563.x.
The objective of this study was to investigate the molecular weight (MW) and time-dependence of the phenomenon termed "the enhanced permeability and retention" (EPR) effect in solid tumor, in particular to determine and define the early phase accumulation of macromolecules in tumor and normal tissues and the relationship between blood concentration and tissue clearance. As a model, radioiodinated N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers of MW ranging from 4.5 K to 800 K were administered i.v. to mice bearing sarcoma 180 tumor. Within 10 min all HPMA copolymers accumulated effectively in the tumor regardless of MW (1.0-1.5% of injected dose per g of tumor). However, higher MW copolymers (> 50 K) showed significantly increased tumor accumulation after 6 h, while the lower MW copolymers (< 40 K) were cleared rapidly from tumor tissue due to rapid diffusion back into the bloodstream. Blood clearance was also MW-dependent; the lower MW copolymers displayed rapid clearance, with kidney radioactivity of the copolymers of MW < 20 K representing 24% of injected dose per g kidney at 1 min after i.v. administration. Within 10 min these copolymers passed through the kidney and were excreted in the urine. Higher MW copolymers consistently showed kidney levels of 3-5% dose per g kidney in the early phase with no time-dependent accumulation in kidney. There was also no progressive accumulation in muscle or liver, regardless of polymer MW. These results suggest the "EPR effect" in solid tumor primarily arises from in the difference in clearance rate between the solid tumor and the normal tissues after initial penetration of the polymers into these tissues.
本研究的目的是调查实体瘤中所谓“增强的渗透与滞留”(EPR)效应的分子量(MW)及时间依赖性,特别是确定并界定大分子在肿瘤组织和正常组织中的早期蓄积情况,以及血药浓度与组织清除率之间的关系。作为模型,将分子量范围为4.5K至800K的放射性碘化N-(2-羟丙基)甲基丙烯酰胺(HPMA)共聚物静脉注射给患有肉瘤180肿瘤的小鼠。在10分钟内,所有HPMA共聚物均有效地蓄积在肿瘤中,而与分子量无关(每克肿瘤组织中为注射剂量的1.0 - 1.5%)。然而,较高分子量的共聚物(> 50K)在6小时后肿瘤蓄积显著增加,而较低分子量的共聚物(< 40K)由于迅速扩散回血液中而从肿瘤组织中快速清除。血液清除率也与分子量有关;较低分子量的共聚物显示出快速清除,静脉注射后1分钟时,分子量< 20K的共聚物在肾脏中的放射性占每克肾脏注射剂量的24%。在10分钟内,这些共聚物通过肾脏并随尿液排出。较高分子量的共聚物在早期阶段肾脏水平始终为每克肾脏3 - 5%剂量,且在肾脏中无时间依赖性蓄积。无论聚合物分子量如何,在肌肉或肝脏中也没有进行性蓄积现象。这些结果表明,实体瘤中的“EPR效应”主要源于聚合物最初渗透进入这些组织后,实体瘤与正常组织在清除率上的差异。